OJJDP FY25 Juvenile Drug Treatment Court Program – Invited to Apply Administrative Funding Adjustment
ID: 356954Type: Posted
Overview

Buyer

Office of Juvenile Justice Delinquency Prevention (USDOJ-OJP-OJJDP)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Law, Justice and Legal Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Additional Information

See Invitation Letter
Timeline
    Description

    The Office of Juvenile Justice Delinquency Prevention (OJJDP) is inviting applications for the FY25 Juvenile Drug Treatment Court Program, aimed at enhancing the capacity of various governmental entities to improve juvenile drug treatment courts. This initiative seeks to implement innovative approaches that address the needs of youth facing substance use or co-occurring mental health disorders, particularly those with trauma histories. The program is critical for fostering better outcomes for affected youth and is expected to award a total of $1 million, with a maximum award ceiling of $1 million and a minimum of $0. Interested applicants, specifically the City of Florence, Alabama, must submit their proposals by November 18, 2024, and can reach out to Charles Holloway at Charles.Holloway@usdoj.gov for further information.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families." This program aims to enhance and expand comprehensive treatment, early intervention, and recovery support services for adolescents aged 12-18 and transitional aged youth aged 16-25 who are facing substance use disorders and/or co-occurring mental health disorders, along with their families or primary caregivers. The initiative is crucial for addressing the growing need for effective support systems in mental health and substance use treatment for young individuals. The estimated total program funding is $800,000, with one award expected, and interested applicants can reach out to Andrea Harris at andrea.harris@samhsa.hhs.gov or (240) 276-2441 for further information. The synopsis is anticipated to be posted on December 16, 2024, for the fiscal year 2025.
    Behavioral Health Partnership for Early Diversion of Adults and Youth
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Behavioral Health Partnership for Early Diversion of Adults and Youth." This program aims to establish or expand initiatives that divert individuals with mental illness or co-occurring disorders from the criminal or juvenile justice systems to community-based mental health and substance use disorder services prior to arrest and booking. Such programs are crucial for enhancing public health and safety by providing necessary support to vulnerable populations. The estimated total program funding is $2 million, with approximately six awards expected, and interested applicants can reach out to Roxanne Castenada at roxanne.castenada@samhsa.hhs.gov or (240) 276-1917 for further information. The synopsis is anticipated to be posted on December 16, 2024, for the fiscal year 2025.
    HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Clinical Research Hubs, which requires a UM1 clinical trial. This initiative aims to address the opioid overdose crisis by researching effective interventions for individuals with substance use disorders (SUD) within the criminal justice system, focusing on optimizing treatment and enhancing collaboration between justice and community health agencies. The program anticipates funding 8-10 awards, with a total budget of approximately $14 million over five years, and emphasizes the importance of stakeholder engagement and diverse perspectives in the research process. Interested applicants must submit their proposals by January 22, 2025, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov.
    UCEDD National Training Initiative to Support Youth with Intellectual and Developmental Disabilities involved with the Juvenile Justice System
    Active
    Administration for Community Living
    The Administration for Community Living (ACL) is forecasting a grant opportunity titled "UCEDD National Training Initiative to Support Youth with Intellectual and Developmental Disabilities involved with the Juvenile Justice System." This initiative aims to establish a national training center through a competitive five-year grant awarded to an existing University Center for Excellence in Developmental Disabilities Education, Research, and Service (UCEDD) or a group of UCEDDs, focusing on building community capacity to support youth with intellectual and developmental disabilities (ID/DD) who are involved with or at risk of entering the juvenile justice system. The center will develop culturally competent, person-centered training programs in collaboration with various stakeholders, including juvenile justice staff, educational representatives, and family members of affected youth. The estimated funding for this opportunity ranges from $350,000 to $500,000, with applications accepted only from the 67 designated UCEDDs, and the expected award date is September 1, 2022. Interested applicants can reach out to Dana Fink at dana.fink@acl.hhs.gov or call 202.795.7604 for more information.
    Sober Truth on Preventing Underage Drinking Act (STOP Act) Grant Program
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting the availability of the Sober Truth on Preventing Underage Drinking Act (STOP Act) Grant Program, aimed at preventing and reducing alcohol use among youth and young adults aged 12-20 across the United States. This grant program seeks to address various factors related to underage drinking, including social norms, enforcement efforts, and penalties, while building on strategic plans developed under previous Drug Free Communities (DFC) grants. With an estimated total program funding of $749,000 and an expected 12 awards, eligible applicants include domestic public and private nonprofit entities that are current or former DFC Support Program recipients. Interested parties can reach out to Jerry Campbell at (240) 276-0117 or via email at CSAP.DPP@samhsa.hhs.gov for further information, with the synopsis expected to be posted on November 15, 2024.
    Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose." This funding opportunity aims to support research that evaluates prevention strategies aimed at reducing nonfatal and fatal overdoses, particularly among populations at higher risk due to social determinants of health. The initiative is crucial for addressing the ongoing public health crisis related to drug overdoses and substance use disorders, especially among youth. The estimated total program funding is $4.9 million, with an award ceiling of $700,000 and an expected seven awards to be made. Interested applicants must submit their proposals electronically by December 2, 2024, and can direct inquiries to Candis M. Hunter at ncipcerpo@cdc.gov.
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)." This initiative aims to support Small Business Technology Transfer (STTR) grant applications focused on developing innovative and accessible solutions to improve health outcomes for individuals affected by non-disordered drug use. The program emphasizes the creation of affordable interventions that can be implemented in community-based care systems, targeting vulnerable populations with limited access to traditional healthcare services. Funding amounts of up to $400,000 for Phase I and $3 million for Phase II are available, with applications due by December 3, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Drug-Free Communities (DFC) Support Program - NEW (Year 1)
    Active
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen community coalitions focused on preventing youth substance use, with the overarching goals of fostering collaboration among various stakeholders and reducing substance abuse among youth and adults. Eligible applicants include nonprofit organizations with 501(c)(3) status, community-based coalitions, and other entities that support these initiatives, with a total estimated funding of $62.5 million and an award ceiling of $125,000 per grant. Interested parties should note that applications must be submitted electronically by March 25, 2025, and can direct inquiries to Brandis Belser at dfcnofo@cdc.gov.